Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.9100
+0.0249 (2.81%)
Apr 29, 2025, 12:58 PM EDT - Market open
Kronos Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 84.57 | 64.33 | 75.97 | 198.27 | 248.01 | Upgrade
|
| Short-Term Investments | 27.85 | 108.67 | 162.21 | 141.24 | 165.05 | Upgrade
|
| Cash & Short-Term Investments | 112.42 | 173 | 238.19 | 339.51 | 413.06 | Upgrade
|
| Cash Growth | -35.02% | -27.37% | -29.84% | -17.81% | 348.08% | Upgrade
|
| Other Receivables | - | - | - | 0.82 | 0.61 | Upgrade
|
| Receivables | - | - | - | 0.82 | 0.61 | Upgrade
|
| Prepaid Expenses | 2.51 | 5.38 | 6.11 | 6.25 | 5.01 | Upgrade
|
| Other Current Assets | 0.3 | 0.4 | - | 0.98 | 1.12 | Upgrade
|
| Total Current Assets | 115.23 | 178.78 | 244.29 | 347.55 | 419.8 | Upgrade
|
| Property, Plant & Equipment | 7 | 29.91 | 37.69 | 41.78 | 40.97 | Upgrade
|
| Long-Term Investments | - | 1.99 | 9.76 | - | 49 | Upgrade
|
| Other Long-Term Assets | 2.14 | 2.6 | 3.19 | 2.14 | 2.19 | Upgrade
|
| Total Assets | 124.36 | 213.28 | 294.94 | 391.48 | 511.96 | Upgrade
|
| Accounts Payable | 2.4 | 0.88 | 5.05 | 1 | 4.55 | Upgrade
|
| Accrued Expenses | 3.55 | 10.78 | 12.92 | 9.06 | 3.49 | Upgrade
|
| Current Portion of Leases | 3.39 | 2.89 | 2.35 | 2.11 | 0.94 | Upgrade
|
| Current Income Taxes Payable | 0.03 | 0.13 | 0.04 | - | 0.56 | Upgrade
|
| Current Unearned Revenue | 1.86 | 9.58 | - | - | - | Upgrade
|
| Other Current Liabilities | 4.04 | 0.42 | 1.13 | 1.46 | 3.32 | Upgrade
|
| Total Current Liabilities | 15.28 | 24.7 | 21.49 | 13.63 | 12.86 | Upgrade
|
| Long-Term Leases | 21.51 | 25.38 | 28.74 | 31.65 | 31.12 | Upgrade
|
| Long-Term Unearned Revenue | - | 4.13 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.21 | 1.1 | 2.47 | Upgrade
|
| Total Liabilities | 36.78 | 54.2 | 50.44 | 46.38 | 46.45 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 682.45 | 667.86 | 641.42 | 608.06 | 577.39 | Upgrade
|
| Retained Earnings | -594.94 | -508.86 | -396.19 | -262.98 | -111.91 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.02 | -0.79 | -0.04 | -0.02 | Upgrade
|
| Total Common Equity | 87.58 | 159.08 | 244.5 | 345.1 | 465.52 | Upgrade
|
| Shareholders' Equity | 87.58 | 159.08 | 244.5 | 345.1 | 465.52 | Upgrade
|
| Total Liabilities & Equity | 124.36 | 213.28 | 294.94 | 391.48 | 511.96 | Upgrade
|
| Total Debt | 24.9 | 28.27 | 31.09 | 33.76 | 32.06 | Upgrade
|
| Net Cash (Debt) | 87.52 | 144.73 | 207.09 | 305.75 | 381 | Upgrade
|
| Net Cash Growth | -39.52% | -30.12% | -32.27% | -19.75% | 315.71% | Upgrade
|
| Net Cash Per Share | 1.46 | 2.51 | 3.68 | 5.58 | 23.41 | Upgrade
|
| Filing Date Shares Outstanding | 60.97 | 60.1 | 57.63 | 56.6 | 56.05 | Upgrade
|
| Total Common Shares Outstanding | 60.46 | 58.95 | 56.97 | 55.7 | 54.07 | Upgrade
|
| Working Capital | 99.95 | 154.08 | 222.81 | 333.93 | 406.95 | Upgrade
|
| Book Value Per Share | 1.45 | 2.70 | 4.29 | 6.20 | 8.61 | Upgrade
|
| Tangible Book Value | 87.58 | 159.08 | 244.5 | 345.1 | 465.52 | Upgrade
|
| Tangible Book Value Per Share | 1.45 | 2.70 | 4.29 | 6.20 | 8.61 | Upgrade
|
| Machinery | 8.28 | 8.84 | 9.15 | 8.8 | 5.84 | Upgrade
|
| Leasehold Improvements | 4.14 | 8.7 | 9.35 | 9.34 | 8.96 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.